Jarosław Kałużny

Dr. Jarosław Kałużny

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Otolaryngologia Polska
Verified
Journal Article
Closed access
JKJarosław Kałużny
Jarosław Kałużny
MWMałgorzata Wierzbicka
Małgorzata Wierzbicka
HNHanna Nogala
Hanna Nogala
PMPiotr Milecki
Piotr Milecki
TKTomasz Kopeć
Tomasz Kopeć
Definition and prevalence of xerostomia were shortly presented. Radiosensitivity of the salivary glands, mechanism, diagnostics, and possible prediction methods of the intensity of xerostomia in the pre-radiotherapy period are widely discussed. Prevention of xerostomia: salivary gland sparing radiotherapy, cytoprotective agents, preservation by stimulation with cholinergic muscarinic agonists, surgical transfer of submandibular glands according to ASCO Management Guidelines and Quality of Life Recommendations were cited. Oral Care Study Group (2010) therapeutic approaches for relieving xerostomia are referred. Current therapies, restricted to symptom relief such as oral hygiene with fluoride agents, antimicrobials to prevent dental caries, saliva substitutes to relieve symptoms, and sialogenic agents to stimulate saliva were also discussed.

1 January 2014 in Medical Science Monitor
Verified
Journal Article
Open access
PDF file
WSWitold Szyfter
Witold Szyfter
MWMałgorzata Wierzbicka
Małgorzata Wierzbicka
JKJarosław Kałużny
Jarosław Kałużny
MRMarek Ruchała
Marek Ruchała
MSMarek Stajgis
Marek Stajgis
TKTomasz Kopeć
Tomasz Kopeć
Background:Shear wave elastography (SWE) is widely used in breast, liver, prostate and thyroid evaluations. Elastography provides additional information if used to assess parotid gland pathology. We assessed parotid glands by means of SWE to compare ...

Verified
Journal Article
Open access
PDF file
MKMałgorzata Kałużna
Małgorzata Kałużna
PKPola Kompf
Pola Kompf
MRMichal Rabijewski
Michal Rabijewski
JMJerzy A. Moczko
Jerzy A. Moczko
JKJarosław Kałużny
Jarosław Kałużny
MRMarek Ruchala
Marek Ruchala
(1) Background: Isolated hypogonadotropic hypogonadism (IHH) is a genetic condition characterized by impaired puberty and fertility. IHH can significantly impact patient health-related quality of life (HRQoL), sexual satisfaction (SS) and mood. (2) Methods: Participants included 132 IHH subjects (89 men and 43 women) and 132 sex- and age-matched controls. HRQoL, depressive symptoms, erectile dysfunction (ED), and SS were assessed in an online survey using the Zung Self-Rating Depression Scale (SDS), 15D instrument of HRQoL (15D), Sexual Satisfaction Questionnaire (SSQ), and 5-item International Index of Erectile Function (IIEF-5). (3) Results: QoL and SS were significantly lower in the IHH group vs. controls. There was a high rate of ED (53.2% vs. 33%, p = 0.008) and depressive symptoms (45.00 ± 17.00 vs. 32.00 ± 12.00, p < 0.001) in patients vs. controls. The age of patients at IHH diagnosis inversely correlated with their overall 15D scores. An alarming non-compliance rate was seen (51.6%). No differences were found between scores of patients receiving hormone replacement therapy (HRT) and untreated subjects in any of the scales. (4) Conclusions: The HRQoL, SS, ED, and depression levels observed in IHH patients, despite HRT, are alarming. Late IHH diagnosis may have a particularly negative impact on HRQoL. More attention should be devoted to HRT adherence and various HRQoL aspects of IHH patients.

5 June 2021 in Genes
Verified
Journal Article
Open access
PDF file
MKMałgorzata Kałużna
Małgorzata Kałużna
BBBartlomiej Budny
Bartlomiej Budny
MRMichal Rabijewski
Michal Rabijewski
JKJarosław Kałużny
Jarosław Kałużny
ADAgnieszka Dubiel
Agnieszka Dubiel
KZKatarzyna Ziemnicka
Katarzyna Ziemnicka
Kallmann syndrome (KS) is a combination of isolated hypogonadotropic hypogonadism (IHH) with olfactory dysfunction, representing a heterogeneous disorder with a broad phenotypic spectrum. The genetic background of KS has not yet been fully established. This study was conducted on 46 Polish KS subjects (41 males, 5 females; average age: 29 years old). The studied KS patients were screened for defects in a 38-gene panel with next-generation sequencing (NGS) technology. The analysis revealed 27 pathogenic and likely pathogenic (P/LP) variants, and 21 variants of uncertain significance (VUS). The P/LP variants were detected in 20 patients (43.5%). The prevalence of oligogenic P/LP defects in selected genes among KS patients was 26% (12/46), whereas the co-occurrence of other variants was detected in 43% (20 probands). The examined KS patients showed substantial genotypic and phenotypic variability. A marked difference in non-reproductive phenotypes, involving defects in genes responsible for GnRH neuron development/migration and genes contributing to pituitary development and signaling, was observed. A comprehensive gene panel for IHH testing enabled the detection of clinically relevant variants in the majority of KS patients, which makes targeted NGS an effective molecular tool. The significance of oligogenicity and the high incidence of alterations in selected genes should be further elucidated.